Bausch Health Companies I...

NYSE: BHC · Real-Time Price · USD
8.34
0.83 (11.05%)
At close: Aug 15, 2025, 3:59 PM
8.35
0.12%
After-hours: Aug 15, 2025, 05:46 PM EDT

Bausch Health Companies Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.5B 2.23B 2.46B 2.51B 2.4B 2.14B 2.41B 2.24B 2.17B 1.94B 2.19B 2.05B 1.97B 1.92B 2.2B 2.11B 2.1B 2.03B
Cost of Revenue
16M 701M 727M 977.8M 988.8M 909.92M -1.81B 623M 649M 582M 652M 584M 577M 551M 626M 582M 612M 574M
Gross Profit
2.49B 1.53B 1.74B 1.53B 1.41B 1.23B 4.22B 1.61B 1.52B 1.36B 1.54B 1.46B 1.39B 1.37B 1.57B 1.53B 1.49B 1.45B
Operating Income
444M 276M 558M 318M 425.91M 292.69M 362M 14M 412M 175M 397M 244M 289M 285M 367M 574M -270M -221M
Interest Income
13M 11M 9M 7M 8M 9M 7M 6M 7M 6M 6M 3M 3M 2M 1M 2M 2M 2M
Pretax Income
140M -47M 209M -21M 47.99M -68.69M -7M -326M 79M -136M -357M 439M -129M -82M 21M 216M -670M -591M
Net Income
148M -58M 90.38M -85M 10M -63.71M 395M -378M 26M -209M -410M 399M -139M -66M 69M 188M -595M -610M
Selling & General & Admin
894M 867M 820M 850M 831.83M 790.45M 766M 715M 711M 725M 666M 661M 676M 622M 680M 653M 685M 606M
Research & Development
159M 143M 158.4M 161M 155.97M 150.33M 152M 153M 156M 143M 142M 133M 127M 127M 117M 121M 115M 112M
Other Expenses
n/a 272M 309M n/a -3M n/a n/a -60M -1.33M 296M 342M n/a 302M 310M 320M 338M 902M 30M
Operating Expenses
1.05B 1.28B 1.27B 996M 987.8M 940.78M 918M 1.12B 1.05B 1.16B 1.15B 1.08B 1.1B 1.06B 1.16B 1.11B 1.7B 1.07B
Interest Expense
-465M 330M 337M 346M 350M 355M 363M 339M 319M 307M 307M 385M 410M 362M 343M 351M 364M 368M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 625M n/a n/a n/a 518M n/a n/a n/a 515M n/a n/a n/a
Cost & Expenses
1.07B 1.98B 2B 1.98B 1.98B 1.85B -896M 1.74B 1.7B 1.75B 1.8B 1.67B 1.68B 1.61B 1.79B 1.69B 2.31B 1.65B
Income Tax Expense
-12M 39M 111M 71.57M 48.99M 7.96M -402M 56M 52M 73M 53M 36M 10M -16M -51M 25M -77M 16M
Shares Outstanding (Basic)
370.9M 362.5M 372M 368.4M 367.9M 366.8M 365.24M 365.4M 364.8M 363.3M 361.9M 362.5M 362.2M 360.8M 360M 359.6M 358.43M 356.8M
Shares Outstanding (Diluted)
373.1M 362.5M 372M 368.4M 370.2M 366.8M 365.24M 365.4M 367.1M 363.3M 361.9M 363.4M 362.5M 360.8M 364.1M 364M 358.43M 363.5M
EPS (Basic)
0.40 -0.16 0.25 -0.23 0.03 -0.17 1.08 -1.03 0.07 -0.58 -1.13 1.10 -0.38 -0.18 0.24 0.66 -1.66 -1.71
EPS (Diluted)
0.40 -0.16 0.25 -0.23 0.03 -0.17 1.08 -1.03 0.07 -0.58 -1.13 1.10 -0.38 -0.18 0.24 0.66 -1.66 -1.68
EBITDA
444M 276M 853M 647M 718.85M 606.28M 836M 310.01M 741M 490.04M 310.47M 713M 622.65M 639.76M 857M 942.54M 97.17M 181.34M
EBIT
614.97M 283M 546M 330.64M 400.92M 286M 356M 12.83M 403.25M 171.01M -50M 824M 278.61M 283.44M 364M 563.14M -303.4M -223M
Depreciation & Amortization
n/a -7M 307M 324.59M 317.93M 318.57M 338.09M 297.18M 319.16M 319.02M 360.54M 335M 344.04M 356.32M 361.78M 379.4M 400.57M 406.01M